Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib vs Diclofenac for Early Morning Activity in RA
NCT01067430Phase 4Withdrawn
- Sponsor
- Northumbria Healthcare NHS Foundation Trust
- Start
- Apr 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of etoricoxib in rheumatoid arthritis (RA), sponsored by Northumbria Healthcare NHS Foundation Trust. Planned start Apr 2010; status: withdrawn.
02
Drugs
etoricoxib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01067430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01067430.